Vitamin B deficiencies, which can lead to hyperhomocysteinemia (Hhcy), are commonly reported in patients with inflammatory bowel disease (IBD) and may be a causative underlying factor. However, the mechanism for this effect is not known. Hydrogen sulfide (H 2 S) is a gaseous mediator that promotes tissue repair and resolution of inflammation. In experimental colitis, a marked increase in colonic H 2 S synthesis drives ulcer healing and resolution of inflammation. Because H 2 S synthesis is in part dependent upon enzymes that require vitamin B 6 as a cofactor, we tested the hypothesis that Hhcy in rodent models would increase the susceptibility to colitis. In all three models tested, diet-induced Hhcy significantly exacerbated colitis. The usual elevation of colonic H 2 S synthesis after induction of colitis was absent in all three models of colitis. Administration of an H 2 S donor to Hhcy rats significantly decreased the severity of colitis. Compared with wild-type mice, interleukin (IL) 10-deficient mice on a normal diet had decreased levels of colonic H 2 S synthesis, a 40% increase in serum homocysteine, and a phenotype similar to wild-type mice with Hhcy. IL-10-deficient mice fed the vitamin B-deficient diet exhibited more severe colonic inflammation, but the normal elevation of colonic H 2 S synthesis was absent. Administration of IL-10 to the IL-10-deficient mice restored colonic H 2 S synthesis and significantly decreased serum homocysteine levels. These results suggest that the exacerbation of colitis in Hhcy is due in part to impaired colonic H 2 S synthesis. Moreover, IL-10 plays a novel role in promoting H 2 S production and homocysteine metabolism, which may have therapeutic value in conditions characterized by Hhcy. V itamin deficiencies are commonly reported in patients with inflammatory bowel disease (IBD) and, in most cases, are a consequence of reduced intake or decreased absorption secondary to intestinal injury or surgical resection (1, 2) . One of the most common deficiencies in IBD is of vitamin B 6 , affecting up to 30% of patients (3) . Vitamin B deficiency can result in elevated blood homocysteine levels (hyperhomocysteinemia; Hhcy) (3, 4) . Hhcy is associated with increased risk of thrombosis and microvascular disorders (5, 6), as well as with a significant worsening of IBD (1, 7) . The mechanisms through which Hhcy exacerbates intestinal inflammation are not known.
In recent years, hydrogen sulfide (H 2 S) has become recognized as an important signaling molecule in many organs and tissues (8) , and particularly as an anti-inflammatory and cytoprotective mediator (9) . H 2 S is produced throughout the gastrointestinal (GI) tract, and its synthesis is markedly increased following mucosal injury (10) (11) (12) (13) ). In such settings, H 2 S accelerates repair of damaged tissue and promotes resolution of inflammation (10, 11, 14) . Conversely, inhibition of H 2 S synthesis leads to GI mucosal inflammation and impairment of healing of injury (10, 11, 14, 15) .
There are three enzyme systems for endogenous synthesis of H 2 S, two of which require pyridoxal 5′-phosphate (P5P), the biologically active form of vitamin B 6 , as a cofactor for their activity (8) . The two P5P-dependent enzymes for H 2 S synthesis are cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS). The Hhcy that develops during vitamin B deficiency is in part due to the insufficient conversion of homocysteine to cysteine via P5P-dependent enzymes. This is recapitulated in mice with genetic deficiencies of CSE (16) or CBS (17) . These mice exhibit elevated blood levels of homocysteine (but not cysteine). During colitis, the marked elevation of H 2 S synthesis is primarily due to up-regulation of CSE (11, 14) . The third key pathway for H 2 S synthesis, which is also up-regulated in colitis (14) , involves a P5P-independent enzyme, 3-mercaptopyruvate transferase (3MST) (8) .
It stands to reason that when levels of vitamin B 6 are diminished, there may be an impairment of H 2 S synthesis. We hypothesized that Hhcy-related exacerbation of IBD may be a consequence of diminished intestinal production of H 2 S. To test this hypothesis, we examined the effects of diet-induced vitamin B deficiency in three models of colitis. One of these models was the interleukin (IL) 10-deficient mouse. In addition to choosing this model because it is a genetic model of colitis, rather than chemical, it is also relevant to the human disease because of established links between IBD and defective IL-10 signaling (18, 19) . In the course of our study, we discovered an important regulatory interaction between IL-10 and H 2 S in modulating colonic tissue integrity that appears to be affected by, and be an influence upon, circulating homocysteine levels.
Results
Rats consuming the vitamin B-deficient (B-Def) diet for 7 wk developed significant Hhcy, with plasma homocysteine levels Significance Inflammatory bowel diseases (IBDs) are debilitating conditions with no known cure. Recent evidence suggests that elevated intestinal hydrogen sulfide (H 2 S) synthesis promotes healing and reduces inflammation. H 2 S is synthesized from cysteine largely via vitamin B 6 -dependent enzymes. People with IBD are also at increased risk of hyperhomocysteinemia, a condition that is often caused by vitamin B deficiency. Dietary induction of vitamin B deficiency markedly increased serum homocysteine levels and worsened colitis in rodents. The latter was due to the absence of the typical injury-induced elevation of H 2 S synthesis. Interleukin-10 plays a key role in increasing H2S synthesis, attenuating the severity of colitis, and reducing serum homocysteine levels. The H 2 S-interleukin 10 axis may be a viable target for therapy of IBD. being approximately eightfold greater than for rats consuming the control diet (94.4 ± 15.3 μmol/L vs. 12.6 ± 1.0 μmol/L, respectively; P < 0.001). The mean body weights in the two groups were identical at the start of the study (223 g), but after 6 wk the rats on the B-Def diet exhibited significantly lower body weights (383 ± 5 g vs. 481 ± 7 g in controls; P < 0.01). Effects of Hhcy on the severity of colitis were first examined in the dextran sodium sulfate (DSS) model (20) . In the control group that received normal drinking water during the seventh week of the study, there were no differences between the two diets in terms of the macroscopic or histological appearance of the colon. However, in the rats on the B-Def diet, the basal colonic tissue levels of myeloperoxidase (MPO) were reduced by 75% (P < 0.001) compared with the rats on the control diet. The reduced tissue MPO in rats with Hhcy (Fig. 1C) is consistent with our observation of extensive neutrophil margination/extravasation in these rats and with reports of systemic neutropenia in humans with Hhcy (21, 22) and rats with vitamin B 6 deficiency (23) . When the drinking water was supplemented with DSS during the seventh week, significant weight loss, colonic damage, and inflammation were observed, and these changes were much more severe in the rats on the B-Def diet (Fig. 1) . Colonic MPO levels increased significantly in both groups, but the extent of the increase was much greater in rats on the B-Def diet (12-fold) than in rats on the control diet (3-fold) (Fig. 1C) . Consistent with the increase in the severity of colitis, there was also significantly greater expression of mRNA for tumor necrosis factor (TNF) α, IL-1β, and intercellular adhesion molecule (ICAM) 1 in colonic tissue from the rats on the B-Def diet than those on the control diet. We also observed an increase in colonic tissue expression of mRNA for IL-10, but it was a more variable response than that of the other cytokines (Fig. S1 ). It is noteworthy that the significantly greater severity of colitis in the rats on the B-Def diet occurred despite those rats consuming ∼36% less of the DSSsupplemented water over the final 3 d of the 7-d treatment period. The increased severity of colitis in the rats on the B-Def diet was confirmed by histology ( Fig. 1 D and Fig. S1A ).
Enteric bacteria contribute significantly to the pathogenesis of IBD, and can produce H 2 S (13, 24) . To determine whether the B-Def diet altered enteric bacterial H 2 S production, fecal samples from rats on the two diets were collected over the 6-wk feeding period and their ability to produce H 2 S was determined (13) . There was a transient decrease in H 2 S production in both groups at the end of 1 wk (Fig. S2) , and thereafter fecal H 2 S production in the two groups was indistinguishable.
As described previously (11, 14) , there was a substantial increase in colonic H 2 S synthesis (>7-fold; Fig. 2A ) and colonic CSE expression (>12-fold; Fig. 2B ) in rats on the control diet that received DSS. This increase in H 2 S synthesis has been shown to be crucial in limiting tissue injury and promoting resolution of colitis and healing of ulcers (11, 14) . However, in rats on the B-Def diet, the usual robust increases in colonic H 2 S synthesis and colonic CSE expression were absent ( Fig. 2 A and B) . In contrast to these changes in the colon, induction of colitis and consumption of the B-Def diet had no effect on hepatic H 2 S synthesis (Fig. 2C) . Colonic H 2 S synthesis via the 3MST (P5P-independent) pathway, and 3MST expression, were also elevated in the rats on the normal diet following induction of colitis. However, as was the case for CSE/CBS-derived H 2 S synthesis, the usual increase in colonic H 2 S synthesis observed in rats with colitis was absent when those rats were fed the B-Def diet (Fig. S3) .
Many of the alterations observed in rats fed the B-Def diet were reversed by treatment with an H 2 S donor. Thus, twice-daily administration of diallyl disulfide (DADS) for 7 d during the period when the rats were receiving DSS resulted in a significant reduction in the colonic disease score and tissue MPO activity. Treatment with DADS also resulted in a marked increase in colonic CSE expression and H 2 S synthesis, to similar levels as observed in rats on the control diet following induction of colitis (Fig. S4 ). DADS administration also resulted in significant attenuation of colonic expression of mRNA for TNF-α, IL-1β, and ICAM-1, and a nearsignificant reduction of IL-10 expression (P = 0.07; Fig. S5 ). Thus, administration of the H 2 S donor reversed most of the changes that had been induced by feeding the rats the vitamin B-deficient diet.
Effects of Hhcy were also examined using a hapten-induced model of colitis. Intracolonic dinitrobenzene sulfonic acid (DNBS) administration resulted in severe ulceration and inflammation in rats on both diets. MPO activity in rats on the control diet increased threefold after DNBS administration, whereas in the B-Def group, DNBS provoked an approximately sixfold increase in MPO (P < 0.001; Fig. S6 ). As in the DSS model of colitis, there were marked changes in colonic H 2 S synthesis following induction of colitis with DNBS. Compared with rats fed the control diet, colonic H 2 S synthesis via the CSE/CBS pathways was 91% lower in the rats on the B-Def diet (P < 0.05; Fig. S6B ), whereas colonic H 2 S synthesis via the 3MST pathway was reduced by 61% (P < 0.05; Fig. S6C ). Thus, as in DSS-induced colitis, the severity of DNBS-induced colitis was increased, and the usual increase in colonic H 2 S synthesis was absent in rats on the B-Def diet.
IL-10-deficient mice will spontaneously develop colitis, although the onset and severity vary depending on factors such as the relative cleanliness of animal housing facilities (22) . We therefore used IL-10-deficient mice as a third model to test our hypothesis that a B-Def diet would increase the susceptibility to colitis, but the studies revealed some additional, intriguing data. IL-10-deficient mice fed the control diet for 7 wk did not exhibit overt signs of colitis (consistent with previous studies of these mice in the McMaster Animal Care Facility), and colonic MPO levels were significantly lower (∼70%) than those in wild-type littermates (see Fig. 4A ). The reduced tissue granulocyte numbers (MPO) in IL-10-deficient mice are consistent with observations of neutropenia in humans with impaired IL-10 production (25) . When fed the B-Def diet, significant colonic inflammation developed in both IL-10-deficient and wild-type mice, as indicated by the marked increases in colonic MPO levels (Fig. 3A) . Although the absolute levels of MPO were Fig. 1 . Diet-induced Hhcy exacerbates colitis induced in rats by DSS. When given DSS in drinking water, rats with Hhcy exhibited significant weight loss (A) and developed more severe colitis, as measured by a macroscopic colitis severity score (B), colonic tissue MPO activity (C), and a histological colitis severity score (D). Mean ± SEM with 10 rats per group. *P < 0.05, ***P < 0.001 versus the control diet group (one-way analysis of variance and Dunnett's multiple comparison test). similar in the two groups, the fold increase in MPO in the IL-10-deficient mice was more than double that in the wild-type mice, owing to the fact that the baseline levels of tissue MPO in IL-10-deficient mice were significantly reduced compared with wildtype mice.
IL-10-deficient mice on the control diet exhibited greatly reduced colonic H 2 S synthesis compared with the wild-type mice (Fig. 3B) . When wild-type mice were fed the B-Def diet, they demonstrated the same marked reduction in colonic H 2 S synthesis. Thus, the data from wild-type mice recapitulated what had been observed in the rat studies (vitamin B deficiency leading to impaired colonic H 2 S synthesis). On the other hand, the data from IL-10-deficient mice suggested a "baseline" impairment of colonic H 2 S synthesis in those mice, similar to what could be induced in wild-type mice through vitamin B deficiency/ Hhcy. Because the IL-10-deficient mice were exhibiting a phenotype similar to that of rats with Hhcy with respect to colonic H 2 S synthesis and basal tissue MPO activity, we investigated the possibility that IL-10-deficient mice had elevated serum levels of homocysteine. Indeed, as shown in Fig. 4C , serum homocysteine levels in IL-10-deficient mice were elevated more than fourfold over those of wild-type mice (P < 0.05), achieving concentrations deemed as hyperhomocysteinemic in mice (26) . In contrast, the wild-type mice had serum homocysteine levels in the normal range for that strain (26) .
Administration of IL-10 to these mice twice over 24 h resulted in normalization of colonic H 2 S synthesis, a significant recovery of colonic MPO activity toward that of wild-type mice, and a reduction in serum homocysteine levels to those of wild-type mice (Fig. 4) .
To further examine the potential regulation of IL-10 synthesis by H 2 S, rats (n = 5 each) were treated intraperitoneally with either an inhibitor of H 2 S synthesis (L-propargylglycine; 25 mg/kg) or with an H 2 S donor (NaHS; 100 μmol/kg), and serum IL-10 levels were measured 4 h later. Serum levels of IL-10 in vehicletreated rats averaged 55 ± 4 pg/mL. The inhibitor of H 2 S synthesis significant decreased serum IL-10 levels (by 45%; P < 0.05), Fig. 2 . Damage-associated elevations in colonic H 2 S synthesis were abolished in rats with diet-induced Hhcy. Induction of colitis with DSS resulted in a marked elevation in colonic H 2 S synthesis (A) in rats on a control diet, but the increase in H 2 S synthesis was absent in the rats with diet-induced Hhcy. The increase in H 2 S synthesis was likely due largely to the increase in expression of CSE, a key enzyme for H 2 S synthesis (B), which was absent in rats with diet-induced Hhcy. Neither colitis nor Hhcy significantly changed H 2 S synthesis in the liver (C). Mean ± SEM with 10 rats per group. **P < 0.01, ***P < 0.001 versus the control diet group; ψ P < 0.05 versus the corresponding control diet group (one-way analysis of variance and Dunnett's multiple comparison test). Fig. 3 . IL-10-deficient mice exhibit impaired colonic H 2 S synthesis and increased colonic inflammation in response to a vitamin B-deficient diet. IL-10-deficient mice on the control diet had significantly lower colonic levels of MPO than wild-type mice (A) and reduced colonic H 2 S synthesis (B). Mean ± SEM for six mice per group (*P < 0.05 versus the corresponding mice on the control diet; ψ P < 0.05 versus the corresponding wild-type group; ANOVA and Dunnett's multiple comparison test).
whereas the H 2 S donor significantly increased serum IL-10 levels (by 38%; P < 0.05).
Discussion
The incidence of IBD (Crohn disease and ulcerative colitis) has been steadily increasing over the past 7 decades, apparently with earlier age of onset (27, 28) . The causes of IBD remain poorly understood and, as a consequence, its treatment remains a challenge. The present study was undertaken to try to gain a better understanding of the reasons for the significant association between IBD and Hhcy, with the hope of gaining insights that would facilitate development of improved treatment options. We examined the role of hydrogen sulfide in this context because its synthesis occurs largely through vitamin B 6 -dependent enzymes, and it has been shown to play vital roles in modulating GI mucosal defense, accelerating healing of ulcers, and promoting resolution of inflammation (10, 11, 14) . Inhibition of H 2 S synthesis leads to mucosal inflammation, an increase in susceptibility to injury, and impaired healing of damaged tissue (10, 11, 14) .
Conversely, H 2 S donors accelerate ulcer healing and exert significant anti-inflammatory effects in the GI tract and elsewhere (10, 11, 29) . In the present study, induction of Hhcy through feeding animals a diet deficient of B vitamins led to a marked impairment of colonic H 2 S synthesis and a significant increase in the severity of colitis in three different models. These results are consistent with clinical observations of an association between Hhcy and IBD (5, 6). Administration of an H 2 S donor reversed the detrimental effects of the B-def diet. Moreover, studies in IL-10-deficient mice, which can spontaneously develop colitis (30) , revealed a marked impairment of colonic H 2 S synthesis and a modest elevation of serum homocysteine levels, both of which were reversed by administration of IL-10. Moreover, IL-10-deficient mice, like rats with Hhcy, had diminished tissue levels of neutrophils, which was also abolished by treatment with IL-10.
H 2 S is synthesized from cysteine through three different enzyme systems, two of which are dependent upon vitamin B 6 for their activity (8) . We speculated that in Hhcy, the diminished serum levels of cysteine could lead to impaired H 2 S synthesis, and in turn to an increased susceptibility to colitis. The robust increase in colonic H 2 S synthesis that normally occurs after injury was absent in the Hhcy rats, but this impairment was seen with both the vitamin B 6 -dependent and -independent pathways of H 2 S synthesis. One possible explanation is that Hhcy led to a reduced systemic availability of cysteine, as a consequence of reduced conversion of homocysteine to cysteine. However, although a decrease in H 2 S synthesis was clearly evident in the colon, there was no significant alteration of H 2 S synthesis in the liver. Another possible explanation is that Hhcy resulted in decreased expression of enzymes that convert cysteine to H 2 S, particularly CSE. Indeed, we observed a profound reduction in expression of CSE in the colon of rats fed the B-Def diet, and a failure of the normal, rapid up-regulation of CSE expression after administration of colitis-triggering chemicals (DSS or DNBS). Administration of an H 2 S donor restored the up-regulation of CSE expression and, in turn, colonic H 2 S synthesis.
IL-10-deficient mice were used as a third model of colitis and, as in the DSS and DNBS models, feeding these mice a vitamin B-deficient diet resulted in a significant worsening of colitis (e.g., markedly greater increase in colonic MPO activity). However, the IL-10-deficient mice, even on a normal diet, exhibited a phenotype similar to what was observed with rats on the vitamin B-deficient diet. Thus, levels of colonic H 2 S synthesis in the IL-10-deficient mice were significantly lower than in wild-type mice when fed either the control or the vitamin B-deficient diet. As in the rats with Hhcy, the IL-10-deficient mice exhibited marked neutropenia, as has been reported to occur in humans with Hhcy (21, 22) and in rats with vitamin B 6 deficiency (23). The similarity in phenotype between the rats with diet-induced Hhcy and the IL-10-deficient mice was confirmed by measurements of serum homocysteine levels, which confirmed that these mice had mild to moderate Hhcy (31) . Moreover, we confirmed that there is an interplay among IL-10, homocysteine, and H 2 S synthesis, because serum homocysteine levels and colonic H 2 S synthesis could be normalized in the IL-10-deficient mice through administration of recombinant IL-10.
A stimulatory effect of H 2 S on IL-10 expression/synthesis has been demonstrated in several studies. Thus, administration of H 2 S donors has been shown to suppress expression/synthesis of several "proinflammatory" cytokines (e.g., IL-1β, IL-6, IL-8, IL-18, TNF-α, IFN-γ, RANTES, etc.) in a variety of tissues while either sparing or stimulating expression/synthesis of IL-10 (29, (32) (33) (34) (35) . In the present study, treatment of rats with colitis with the H 2 S donor (DADS) resulted in significant suppression of expression of IL-1β, TNF-α, and ICAM-1. Although expression of IL-10 was also reduced, it remained ∼12-fold greater than expression in healthy rats. The ability of H 2 S to modulate IL-10 expression/synthesis was also evident from the observation that Fig. 4 . Administration of recombinant IL-10 (rIL) to IL-10-deficient mice normalized colonic MPO levels and H 2 S synthesis and markedly reduced serum homocysteine levels. Mean ± SEM for six mice per group (*P < 0.05, **P < 0.01, ***P < 0.001 versus wild-type mice; administration of an inhibitor of H 2 S synthesis increased serum IL-10 levels in rats, whereas administration of an H 2 S donor significantly reduced those levels.
There is substantial evidence for IL-10 playing an essential role in modulating intestinal integrity in patients with IBD. Genomewide association studies have established strong links between defective IL-10 production/secretion and the development of IBD (18, 36, 37) . IL-10 plays a critical role in promoting resolution of mucosal inflammation (38) . A loss of this IL-10 signaling results in impaired resolution, which is observed clinically in "very early onset" IBD patients who have a deficiency of IL-10 receptors (18) . There is also evidence for altered IL-10 signaling in patients with Hhcy, including reduced effectiveness of IL-10 in modulating release of matrix metalloprotease 9 (39). Recombinant IL-10 has shown some promise as a therapy for IBD (40) .
Consistent with our findings, there are similarities in vascular responses in IL-10-deficient mice and animals with Hhcy. For example, carotid arteries from IL-10-deficient mice exhibit increased production of superoxide and impaired relaxation of arteries (41) . Impaired vasodilation and endothelial dysfunction are hallmark features of Hhcy, and can be observed in mice deficient of either of the vitamin B 6 -dependent enzymes involved in H 2 S synthesis (16, 42) . Indeed, H 2 S is one of the important endothelial-derived hyperpolarizing factors (43) , raising the possibility, consistent with our observations, that impaired endothelial vasodilation in Hhcy is due, at least in part, to lack of H 2 S production. Homocysteine is able to induce inflammation and vascular dysfunction through its oxidative actions (44) . Conversely, H 2 S has been shown to attenuate or abolish the oxidative injury associated with Hhcy, including that in the GI tract (45) (46) (47) , and to be a potent endogenous anti-inflammatory substance (48) .
In summary, our studies demonstrate that dietary induction of Hhcy results in exacerbation of colitis in three animal models, thus mimicking the clinical scenario in which IBD is more prevalent and severe in patients with elevated homocysteine levels. Furthermore, the absence of a rapid elevation of colonic H 2 S synthesis in animals with Hhcy appears to be a key factor in the observed exacerbation of colitis. There is significant crossregulation of production of H 2 S and IL-10 by one another, which can impact resolution of inflammation in the colon as well as circulating homocysteine levels. These studies suggest that modulation of the IL-10/H 2 S signaling pathway may be a rational target for novel therapeutics for IBD.
Methods and Materials
Animals. Male Wistar rats (125-150 g; Charles River Breeding Farms) and C57BL/ 6J homozygous IL-10-deficient mice (8 wk of age; Jackson Laboratory) were housed in plastic cages and maintained under controlled temperature (20°C), humidity (60%-70%), and light cycle (12 h:12 h light-dark). All experimental protocols were approved by the Animal Research Ethics Board at McMaster University and adhered to the guidelines established by the Canadian Council on Animal Care. The body weights of animals were measured weekly.
Induction of Hyperhomocysteinemia. Rats and mice were provided one of two diets (Harlan Teklad) for 6 wk. One diet ("B-Def") lacked vitamins B 6 , B 9 , and B 12 (49) . The control diet was identical except that it contained the abovementioned vitamins and folate. Both diets contained 1% sulfathiazole to inhibit folate formation by gut bacteria (49) . Fecal samples were collected weekly. Serum homocysteine levels were measured by chemiluminescent microparticle immunoassay (rat) or ELISA (mouse).
Effects of Hhcy on Severity of Colitis. Three models of colitis were used. In the first, after 6 wk on the B-Def or control diet, rats were provided either normal drinking water or drinking water supplemented with dextran sodium sulfate (5% wt/vol; 36-50 kDa) ad libitum. All rats remained on the diets while receiving DSS/water for 7 d. Consumption of drinking water (±DSS) was measured daily.
The second model involved induction of colitis, after 6 wk on the B-Def or control diet, by intracolonic administration of the hapten dinitrobenzene sulfonic acid (50) . Severity of colitis was evaluated 3 d after DNBS administration as described previously (50) .
IL-10-deficient mice were used as the third model of colitis (30) . These mice and wild-type littermates (10 per group) were provided the B-Def or control diet for 7 wk, and severity of colitis was then evaluated.
After the animals were euthanized, the colons were removed, opened by incision along the mesenteric border, and blindly evaluated for disease severity using a modified version of a previously described "disease activity index" (20) . Each animal was scored for the presence of adhesions between the colon and other visceral tissues (0, no adhesions; 1, adhesions present; 2, severe adhesions present), diarrhea (0 or 1 for absence or presence of diarrhea, respectively), and luminal blood (0, no bleeding; 1, presence of blood; 2, frank bleeding).
Histological damage scoring of the colon was performed blindly on formalin-fixed, paraffin-embedded sections stained with H&E using previously described scoring criteria (20, 51) .
Tissue samples were excised from the colon of each animal for measurement of myeloperoxidase, a biochemical marker of tissue granulocyte content (52) .
In some experiments, 8-wk-old IL-10 KO and wild-type mice were treated with 4 μg of recombinant mouse IL-10 (i.p.) in 100 μL of sterile PBS or with vehicle alone (53) . The mice received two doses of IL-10, 12 h apart. Blood was drawn for measurement of plasma homocysteine levels 4 h after the second administration. Colonic tissue was collected for measurement of H 2 S synthesis, MPO activity, and Western blot analysis.
Tissue H 2 S Synthesis. The ability of tissue to produce H 2 S was measured from homogenized tissue in the presence of exogenous substrate using a modified version (10) of a previously described zinc-trapping assay (54) . The homogenates were incubated in the presence/absence of L-cysteine (4 mM) and pyroxidal-5′-phosphate (2 mM).
Effects of an H 2 S Donor on Colitis. Beginning 1 h after DSS (dissolved in drinking water) was provided, groups of rats were treated twice daily, intracolonically, with diallyl disulfide (30 μmol/kg) or vehicle (1% carboxymethylcellulose) for 7 d. DADS exerts protective effects at this dose (15) . The severity of colitis was blindly evaluated 2 h after the final dose. Colonic tissue samples were processed for measurement of MPO activity, histology, RT-PCR, and Western blotting. Primary antibodies for CSE (1:200), 3MST (1:200), and β-actin (1:10,000) were used.
Quantitative PCR. RNA was extracted from colonic tissue and quantitative PCR was performed as previously described (55) . Bioinformatically validated primer assays for mouse CSE, TNF-α, IL-1β, IL-10, and β-actin were used (Qiagen). In addition, a validated, custom-made primer for ICAM-1 was used (10, 11) . All data were analyzed as previously described, with results expressed as fold increase relative to β-actin (55).
Materials. Isoflurane was from Abbott Laboratories. Recombinant, carrier-free, mouse IL-10 was from Cell Signaling. The validated ICAM-1 primer set was from Integrated DNA Technologies. All other reagents were from Sigma-Aldrich.
Statistical Analysis. All data are expressed as the mean ± SEM. Groups of data were compared using a one-way analysis of variance and the Dunnett's multiple comparison test, or the Student t test where appropriate. An associated probability of less than 5% was considered significant.
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Flannigan et al. 10 .1073/pnas.1413390111 Fig. S1 . Colitis induced by dextran sodium sulfate (DSS) was more severe in rats fed a vitamin B-deficient (B-Def) diet than in rats fed a control diet. In the rats on the B-Def diet, there was markedly increased leukocyte margination in blood vessels (A, arrow) than in rats on the control diet. (Scale bars, 100 μm.) The more severe colitis in rats on the B-Def diet was accompanied by markedly increased expression of TNF-α, IL-1β, IL-10, and intercellular adhesion molecule (ICAM) 1 (B-E, respectively). Results are the mean ± SEM of 5-10 rats per group (*P < 0.05, **P < 0.01 versus the corresponding healthy group; ψ P < 0.05 versus the corresponding control diet colitis group; ANOVA and Dunnett's multiple comparison test). Fig. S2 . Production of hydrogen sulfide (H 2 S) by fecal samples from rats provided the vitamin B-deficient diet or control diet for 6 wk. Fecal H 2 S synthesis is derived largely from enteric bacteria (1). There were no significant differences between the two groups at any time point. Under the conditions of this assay, there is negligible H 2 S production from prokaryotic cells in feces. Results are expressed as mean ± SEM for 10 rats per group. . Colitis induced by DSS resulted in a significant increase in colonic H 2 S synthesis via the 3-mercaptopyruvate pathway in rats on the control diet, but not in rats on the vitamin B-deficient diet, despite more severe colitis. Results are expressed as mean ± SEM for 5-10 rats per group (**P < 0.01 versus healthy rats on the same diet; ψ P < 0.05 versus DSS-treated rats on the control diet; ANOVA and Dunnett's multiple comparison test).
Fig. S4.
Treatment with an H 2 S donor reversed the effects of the vitamin B-deficient diet in rats with colitis. Twice-daily treatment of rats with diallyl disulfide (DADS; 30 μmol/kg intracolonically) significantly reduced the severity of colitis as measured by the blindly evaluated "disease score" (A) and colonic myeloperoxidase (MPO) activity (B). Colitis was induced by providing the rats with drinking water supplemented with DSS (administration of DADS had no effect on the amount of water consumed by the rats). DADS administration also significantly increased colonic H 2 S synthesis (C) and expression of cystathionine γ-lyase (CSE), a key enzyme for H 2 S synthesis. The dashed lines in C and D represent the mean levels of H 2 S synthesis and CSE expression, respectively, for healthy rats fed the control diet. Mean ± SEM for six rats per group (*P < 0.05, **P < 0.01 versus the corresponding vehicle-treated group; Student t test). . Colitis induced by dinitrobenzene sulfonic acid is significantly more severe and is accompanied by impaired H 2 S synthesis. Colonic MPO activity, a marker of granulocyte infiltration, was elevated in rats with colitis, but the increase was significantly greater (***P < 0.001) in rats that were fed the vitamin B-deficient diet (A). In rats with colitis, colonic H 2 S synthesis was markedly increased (*P < 0.05 versus the corresponding healthy group) via both the pyroxidal-5′-phosphate-dependent (B) and -independent (C) pathways. However, in rats on the vitamin B-deficient diet, induction of colitis was not accompanied by a significant increase in colonic H 2 S synthesis via either pathway ( ψ P < 0.05 versus the control group with colitis). Results are expressed as mean ± SEM for 5-10 rats per group (ANOVA and Dunnett's multiple comparison test).
